MedPath

Cognitive Behavioral Therapy – Enhanced: A Randomized Controlled Trial comparing online guided self-help to screen-to-screen treatment for Binge Eating Disorder

Conditions
Binge Eating Disorder
Registration Number
NL-OMON24540
Lead Sponsor
Arkin, Novarum center for eating disorders
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

1.binge eating disorder or other specified feeding or eating disorder (OSFED) binge eating disorder classification
2. Age = 18
3.19.5 = BMI < 40
4.Moderately proficient in Dutch
5.Willing to provide contact details including (mobile)phone number
6.Referral letter from their general practitioner (GP)
7.Internet access
8.Computer/tablet at home and willingness to use this for treatment and research purposes
9.Ability to read Overcoming binge eating’ written by Christopher Fairburn
10.Informed consent regarding the study provided by the patient

Exclusion Criteria

1.Acute psychosis, assessed via Structural Clinical interview DSM 5 (SCID5)
2.Acute depression, assessed via SCID5
3.Suicidal ideation, assessed via SCID5
4.Anorexia Nervosa or Bulimia Nervosa
5.Treatment for an eating disorder during the past 6 months
6.Pregnancy
7.Expected absence during treatment period
8.Medication that might influence eating behavior such as, Lithium, Mitrazepine and anti-psychotic stimulants

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameter is to compare the relative treatment efficacy of guided self-help CBT-E versus screen-to-screen CBT-E, reported as robust remission pre- and post-treatment and during follow-up.
Secondary Outcome Measures
NameTimeMethod
Secondary parameters are the efficacy with regard to clinical impairment and quality of life of guided self-help CBT-E in comparison with screen-to-screen CBT-E after treatment and during follow-up and, to investigate the moderating effect of severity of body dissatisfaction and the association of early menarche and body dissatisfaction. Other parameters are the moderating effects of therapeutic alliance between both conditions and the compare cost- efficacy.
© Copyright 2025. All Rights Reserved by MedPath